rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SBFMW
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Sunshine Biopharma earnings missed by $1.20, revenue topped estimates
      Nov 16Investing.comSBFMSBFMW
      Sunshine Biopharma announces 1-for-20 reverse stock split
      Oct 22Investing.comSBFMSBFMW
      Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
      Oct 22Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma Closes $6 Million Equity Offering
      Oct 12Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma Completes $6 Million Public Offering

      Tipranks Press Release.

      Oct 10The Globe and MailSBFMSBFMW
      Sunshine Biopharma closes $6 million public offering
      Oct 9Investing.comSBFMSBFMW
      Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
      Oct 9Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma Prices $6 Million Public Offering at $0.55 Per Unit, Raising Dilution Concerns
      Oct 8Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
      Oct 8Yahoo FinanceSBFMSBFMW
      12 Health Care Stocks Moving In Wednesday's Intraday Session - China SXT Pharmaceuticals (NASDAQ:SXTC), S

      Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 186.0% to $3.58 during Wednesday's regular session. Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 151.31% to $1.0. The company's

      Oct 7BenzingaSBFMSBFMWSXTC
      12 Health Care Stocks Moving In Tuesday's After-Market Session - China SXT Pharmaceuticals (NASDAQ:SXTC)
      Oct 6BenzingaACTUSBFMSBFMWSXTC
      12 Health Care Stocks Moving In Thursday's After-Market Session
      Oct 1BenzingaELUTINBSSBFMSBFMW
      Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know
      Sep 24Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma launches generic ondansetron in Canada
      Sep 24Investing.comSBFMSBFMW
      Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
      Sep 24Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma CEO Authorizes Potential Reverse Stock Split

      Detailed price information for Sunshine Biopharma (SBFM-Q) from The Globe and Mail including charting and trades.

      Sep 17The Globe and MailSBFMSBFMW
      Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

      The Company had previously published laboratory results on its library of Anti-Coronavirus compounds in August 2024 (J. 2024, 67, 13681−13702) and more recently in March 2026 (J.

      Sep 16Yahoo FinanceSBFMSBFMW
      EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies

      Sunshine Biopharma Inc. (NASDAQ:SBFM) on Wednesday announced it advanced its lead Coronavirus drug candidate into IND-enabling studies. The company had previously published laboratory results on its library of compounds in August 2024 and more recently in March 2026. Background and Compound Research The company said that the nominated drug candidate for advanced development displayed nanomolar potency against the viral protease and had broad-spectrum activity against other SARS-CoV-2 variants of

      Sep 16Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma reduces Series B warrant exercise price to $1.2046
      Sep 11Investing.comSBFMSBFMW
      Sunshine Biopharma receives Canadian approval for atenolol tablets
      Aug 31Investing.comSBFMSBFMW
      Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions

      FORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its Atenolol tablets of 25mg, 50mg and 100mg for the Canadian market. Atenolol is the generic equivalent of the brand name, Tenormin®.

      Aug 31Yahoo FinanceSBFMSBFMW
      Sunshine Biopharma reports progress on K1.1 mRNA cancer program
      Aug 26Investing.comSBFMSBFMW
      Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer

      At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

      Aug 26Yahoo FinanceSBFMSBFMW
      EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
      Aug 26BenzingaSBFMSBFMW

      This is the newest page. Registered accounts read further back.